Sandrine Hiret, MD

Institut de Cancérologie de l'Ouest (ICO) · Institut de Cancérologie de l'Ouest (ICO) - Nantes, France

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers in breast cancer

PubMed author-name match

Trials

Studies that name Sandrine Hiret, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:14 UTC. Open this list on ClinicalTrials.gov

N/A
NCT04899492 · Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or Hypnotherapy
Institut Cancerologie de l'Ouest · terminated · Breast Cancer, Gynecologic Cancer, Digestive Cancer · study chair
Ph2
NCT02143219 · Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer
Institut Cancerologie de l'Ouest · completed · Pancreatic Metastatic Cancer, Toxicity · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name in breast cancer.